Post hoc analyses reveal promising results from the LixiLan‐G trial involving adults with type 2 diabetes. Kudos to Dr. Frias, our NRI team, and everyone involved!
https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14068
April 23, 2020 – Post Hoc Analyses Reveal Promising Results from the LixiLan‐G Trial involving Adults with type 2 Diabetes